Clinsys(R) Redefines Resource Services with the Launch of Clinsys ALTERNA(TM)

BEDMINSTER, N.J., April 10 /PRNewswire/ -- Clinsys Clinical Research, a
therapeutically focused global contract research organization, today announced
the launch of Clinsys ALTERNA, which utilizes its Global Project Solution(R)
(Clinsys GPS(R)) to augment clinical resource services. The new division
demonstrates Clinsys' commitment to aligning its service offerings with its
sponsors' and the life sciences industry's continuously evolving staffing
needs.
Clinsys ALTERNA provides customized Phase I-IV clinical trial alternative
solutions to the conventional outsourcing model. The division is a core
element of Clinsys GPS, a unique, highly effective and proven integrated
project management solution that brings the sponsor and the Clinsys project
teams together to collaborate and agree on all aspects of the clinical study-
before, during and after-to ensure the project's success.
"Clinsys ALTERNA provides a targeted and flexible clinical resourcing
model that adapts to best serve a sponsor's trial management needs," said
David E. Williams, Chief Executive Officer of Clinsys. "We devoted the time
and energy required to approach the evolution of resourcing in an innovative
way that both maximizes efficiencies and decreases deliverable timelines."
Drawing on extensive clinical research experience, Clinsys ALTERNA
delivers a custom-designed, time-sensitive clinical solution that enables
sponsors to engage its services in site management, clinical monitoring,
project management, drug safety, regulatory and medical writing on a contract
basis. Clinsys ALTERNA combines therapeutic expertise, clinical screening,
performance reviews, site references and global reach to offer clients the
most dependable and comprehensive alternative approach to their trial needs.
Visit clinsysalterna.com for more information.
About Clinsys Clinical Research, Inc.
Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical
research organization and a Jubilant Organosys company headquartered in
Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina;
Philadelphia, Pennsylvania; Dusseldorf, Germany; Noida and Bangalore, India.
Clinsys provides pharmaceutical, biotechnology and medical device companies a
broad range of clinical research services in support of Phase I-IV drug
development: project management, medical and clinical monitoring, investigator
and patient recruitment, site management, biostatistics, data management, drug
safety, quality assurance, regulatory services and medical writing services.
Clinsys has expertise in a wide range of highly specialized therapeutic areas,
including oncology, cardiovascular, central nervous system, dermatology,
respiratory and allergy/immunology. Clinsys Clinical Research, Ltd., with
operations in Noida and Bangalore, India, provides extensive clinical research
services for Phase I-IV drug development, and operates a clinical pharmacology
unit performing bioavailability and bioequivalence studies as well as
bioanalytical sample analysis, clinical laboratory and pathology services.
Clinsys ALTERNA(TM) (clinsysalterna.com), a division of Clinsys Clinical
Research, Inc., partners with clients globally to provide customized Phase I-
IV clinical trial alternative solutions to the conventional outsourcing model.
For more information, visit clinsys.com.
Contact
Daniele De Leo
Vice President, Clinsys ALTERNA
610.454.7343
ddeleo@clinsysalterna.com

Clinsys, Clinsys Clinical Research, Inc., Clinsys GPS and Global Project
Solution are registered trademarks of Clinsys Clinical Research, Inc. Clinsys
ALTERNA registration pending. (C) Copyright 2008 Clinsys Clinical Research,
Inc. All rights reserved.
SOURCE Clinsys Clinical Research, Inc.

Daniele De Leo, Vice President of Clinsys ALTERNA, +1-610-454-7343,
ddeleo@clinsysalterna.com